Medicine and Dentistry
Atrial Fibrillation
92%
Rapid Amplification of cDNA Ends
52%
Paroxysmal Atrial Fibrillation
42%
Rhythm
17%
Heart Failure
14%
Persistent Atrial Fibrillation
14%
Prevalence
11%
Targeted Therapy
11%
Sinus Rhythm
11%
Physical Activity
10%
Heart Rehabilitation
10%
Heart Atrium Function
9%
Bradycardia
8%
Heart Failure with Preserved Ejection Fraction
8%
Tachycardia
8%
Rehabilitation Engineering
8%
Body Mass Index
8%
Quality of Life
6%
Platelet-Activating Factor
5%
Cardiovascular System
5%
Keyphrases
Atrial Fibrillation
64%
Atrial Fibrillation Progression
39%
Paroxysmal Atrial Fibrillation
18%
Persistent Atrial Fibrillation
15%
Sex Differences
11%
Heart Failure
10%
Risk Factors
10%
Age of Onset
8%
Heart Failure with Preserved Ejection Fraction (HFpEF)
8%
Clinical Utility
8%
Risk Factor Management
8%
Atrial Function
8%
Body Mass Index
8%
Circulating Biomarkers
8%
Targeted Therapy
8%
Gut Microbiome
8%
Failure Data
8%
Trimethylamine N-oxide
8%
Systematic Meta-analysis
8%
Cardiorespiratory Fitness
8%
Meta-analysis
8%
Health Outcomes
8%
Exercise Training
8%
Atrial Fibrillation Treatment
7%
Cardiovascular Disease
7%
Rhythm Control
6%
Sinus Rhythm Maintenance
5%
Pharmacology, Toxicology and Pharmaceutical Science
Atrial Fibrillation
100%
Paroxysmal Atrial Fibrillation
35%
Persistent Atrial Fibrillation
17%
Heart Failure
16%
Prevalence
11%
Biological Marker
10%
Bradycardia
8%
Antiarrhythmic Agent
8%
Microorganism
8%
Trimethylamine
8%
Thrombocyte Activating Factor
5%
